Profil
Max M.
Søgaard currently works at Expres2ion Biotech Holding AB, as Chief Scientific Officer from 2025.
Dr. Søgaard received his graduate degree from the University of Aarhus and doctorate degree from University College London.
Postes actifs de Max M. Søgaard
| Sociétés | Poste | Début |
|---|---|---|
| EXPRES2ION BIOTECH HOLDING AB | Directeur Technique/Scientifique/R&D | 01/01/2020 |
Formation de Max M. Søgaard
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
University of Aarhus
University of Aarhus Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University College London
University College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Expres2ion Biotech Holding AB
Expres2ion Biotech Holding AB BiotechnologyHealth Technology Engages in the development of a portfolio of vaccines for diseases such as COVID-19, influenza, and breast cancer | Health Technology |
















